Oral Mucosal Expression of HIV-1 Receptors,Co-receptors,and α-defensins: Tableau of Resistance or Susceptibility to HIV Infection?

Abstract

The basic premise of whether transmission of HIV-1 through the oral mucosa actually occurs, and through what route, is a topic of intense interest. Our work has focused on HIV-1 receptors/co-receptors and α-defensin-1 in situ in human gingiva. Regardless of HIV-1 infection, the role that C-type lectin receptors might play in periodontal pathogenesis is of great interest. We have shown that the gingival lamina propria, when inflamed, becomes increasingly infiltrated with DC-SIGN+MR+ dermal dendritic cells (DDCs), while the inflamed epithelium shows a decrease in Langerin+ Langerhans cells (LCs). Moreover, DDCs and LCs contribute to the mature CD83+ DC pool in situ, and form immune conjugates with CD4+ T-cells in the lamina propria (Jotwani and Cutler, 2003). This raises the intriguing possibility that oral mucosal DCs may be involved in HIV-1 transfer to T-cells in situ. However, this possibility is tendered by the challenges faced by the virus in gaining access to oral mucosal immune cells, including their ability to survive the salivary defenses, cross the mucosal barrier, resist inactivation by α-defensins, and overcome the paucity of co-receptor CCR5 in (healthy) oral mucosa (i.e., required for productive infection [Jotwani et al., 2004]). To date, there is little evidence of direct infection by HIV-1 of oral mucosal DCs/T cells and other cells in situ. Abbreviations used in this paper: CP, chronic periodontitis; CCR5, chemokine receptor 5; CXCR4, C-X-C receptor 4; DCs, dendritic cells; DC-SIGN, DC-specific ICAM-3 grabbing non-integrin; DDC, dermal dendritic cells; LCs, Langerhans cells; LP, lamina propria; MR, mannose receptor.

Get full access to this article

View all access options for this article.

References

Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, et al. (2000). The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96:3086–3093.

Baron S, Poast J, Cloyd MW (1999). Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. Arch Intern Med 159:303–310.

Baron S, Poast J, Richardson CJ, Nguyen D, Cloyd M (2000). Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism. J Infect Dis 181:498–504.

Cohen MS, Shugars DC, Fiscus SA (2000). Limits on oral transmission of HIV-1. Lancet 356:272.

Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR (1997). Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 185:621–628.

Dale BA (2002). Periodontal epithelium: a newly recognized role in health and disease. Periodontol 2000 30:70–78.

Dwinell MB, Eckmann L, Leopard JD, Varki NM, Kagnoff MF (1999). Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 117:359–367.

Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, et al. (1996). The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2:1240–1243.

Jameson B, Baribaud F, Pohlmann S, Ghavimi D, Mortari F, Doms RW, et al. (2002). Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 76:1866–1875.

10.

Jotwani R, Cutler CW (2003). Multiple dendritic cell (DC) subpopulations in human gingiva and association of mature DCs with CD4+ T-cells in situ. J Dent Res 82:736–741.

11.

Jotwani R, Palucka AK, Al-Quotub M, Nouri-Shirazi M, Kim J, Bell D, et al. (2001). Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol 167:4693–4700.

12.

Jotwani R, Muthukuru M, Cutler CW (2004). Increase in HIV receptors/co-receptors/alpha-defensins in inflamed human gingiva [rapid communication]. J Dent Res 83:371–377.

13.

Lehrer RI, Ganz T (2002). Defensins of vertebrate animals. Curr Opin Immunol 14:96–102.

14.

Liu X, Zha J, Chen H, Nishitani J, Camargo P, Cole SW, et al. (2003). Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes. J Virol 77:3470–3476.

15.

Mackewicz CE, Yuan J, Tran P, Diaz L, Mack E, Selsted ME, et al. (2003). alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS 17:F23–F32.

16.

Quiñones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, et al. (2003). Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17:F39–F48.

17.

Rothenberg RB, Scarlett M, del Rio C, Reznik D, O’Daniels C (1998). Oral transmission of HIV. AIDS 12:2095–2105.

18.

Sawaki K, Mizukawa N, Yamaai T, Yoshimoto T, Nakano M, Sugahara T (2002). High concentration of beta-defensin-2 in oral squamous cell carcinoma. Anticancer Res 22:2103–2107.

19.

Shugars DC, Sweet SP, Malamud D, Kazmi SH, Page-Shafer K, Challacombe SJ (2002). Saliva and inhibition of HIV-1 infection: molecular mechanisms. Oral Dis 8(Suppl 2):169–175.

20.

Simmons G, Reeves JD, Hibbitts S, Stine JT, Gray PW, Proudfoot AE, et al. (2000). Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev 177:112–126.

21.

Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, Doms RW, et al. (2002). Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol 3:975–983.

22.

Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD (1998). In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 72:5035–5045.

23.

Zhang L, Yu W, He T, Yu J, Caffrey RE, Dalmasso EA, et al. (2002). Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298:995–1000.